Generic Medicine Info
Special Precautions
Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.
Adverse Reactions
Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea.
Drug Interactions
Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs.
CIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
ATC Classification
A03FA09 - mosapride
Disclaimer: This information is independently developed by CIMS based on mosapride from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in